Tarsus Pharmaceuticals Inc (TARS) stock news · rev $451.4M
Tarsus Pharmaceuticals Inc (TARS) is a biotechnology company listed on NASDAQ.
This TARS news page leads with what Tarsus Pharmaceuticals Inc filed — not a scraped headline mill.
No cached 8-K sentence for TARS yet. We will not pad this page with generic market recap.
Latest reported TARS revenue for 2025-12-31 was $451.4M. Net income was -$66.4M. Revenue was up 146.7% from 2024-12-31 to 2025-12-31. TARS currently screens at market cap $2.66B.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the TARS stock page; for the tape open the quote page.
TARS stock news FAQ
What are TARS's latest revenue and net income?
Latest cached Tarsus Pharmaceuticals Inc (TARS) revenue for Dec 31, 2025 was $451.4M. Net income was -$66.4M. Statements: https://lician.com/financials/tars
How did TARS revenue change from the prior cached period?
Cached Tarsus Pharmaceuticals Inc (TARS) revenue was up 146.7% from $183.0M (Dec 31, 2024) to $451.4M (Dec 31, 2025). Statements: https://lician.com/financials/tars
What is TARS's market cap?
Tarsus Pharmaceuticals Inc (TARS) market cap is $2.66B on the latest cached fundamentals snapshot.
What kind of company is TARS?
Tarsus Pharmaceuticals Inc (TARS) is a biotechnology company listed on NASDAQ.
Where is TARS stock news listed?
Cached stock news for Tarsus Pharmaceuticals Inc (TARS) is listed at https://lician.com/news/tars. Filings: https://lician.com/sec/tars
Not investment advice.